Jonathan Lim, Associate Faculty at Cancer Research UK Manchester Institute, shared on LinkedIn:
“Is the brain really immune privileged?
Join us for the next Manchester Immuno-Oncology Network (MION) event as we rethink immunotherapy for brain tumours – bringing together clinical, translational and fundamental research perspectives.
We’ll explore:
- Immunotherapy strategies in glioblastoma
- How local treatments might modulate anti-tumour immunity
- The Brain Tumour Consortium and opportunities for collaboration
- Liquid biopsy approaches for brain tumour detection and monitoring
A great opportunity to hear from colleagues across Manchester and beyond; and, importantly, to connect people interested in advancing immuno-oncology for brain tumours.
Tuesday 13 October 2026 at 15:00-17:00.
Oglesby Building, Manchester Cancer Research Centre.
All welcome – please join us and share with colleagues who may be interested!”
You may also be interested in: GPNMB CAR-T: Targeting Glioblastoma and Its Immune Microenvironment
